199 related articles for article (PubMed ID: 28346060)
21. Induced pluripotent stem cell (iPSC) models of bipolar disorder.
O'Shea KS; McInnis MG
Neuropsychopharmacology; 2015 Jan; 40(1):248-9. PubMed ID: 25482177
[No Abstract] [Full Text] [Related]
22. Modeling schizophrenia using induced pluripotent stem cell-derived and fibroblast-induced neurons.
Tran NN; Ladran IG; Brennand KJ
Schizophr Bull; 2013 Jan; 39(1):4-10. PubMed ID: 23172000
[TBL] [Abstract][Full Text] [Related]
23. [Modeling neurological and psychiatric disorders in vitro using induced pluripotent stem cells: highlighting findings in Alzheimer's disease and schizophrenia].
Hathy E; Kalman S; Apati A; Nemoda Z; Rethelyi JM
Neuropsychopharmacol Hung; 2016 Dec; 18(4):188-198. PubMed ID: 28259862
[TBL] [Abstract][Full Text] [Related]
24. iPS cell derived neuronal cells for drug discovery.
Heilker R; Traub S; Reinhardt P; Schöler HR; Sterneckert J
Trends Pharmacol Sci; 2014 Oct; 35(10):510-9. PubMed ID: 25096281
[TBL] [Abstract][Full Text] [Related]
25. A dangerous method? The use of induced pluripotent stem cells as a model for schizophrenia.
Jacobs BM
Schizophr Res; 2015 Oct; 168(1-2):563-8. PubMed ID: 26194993
[TBL] [Abstract][Full Text] [Related]
26. Stem cells: A path towards improved epilepsy therapies.
Lybrand ZR; Goswami S; Hsieh J
Neuropharmacology; 2020 May; 168():107781. PubMed ID: 31539537
[TBL] [Abstract][Full Text] [Related]
27. Serotonin in psychiatry: in vitro disease modeling using patient-derived neurons.
Vadodaria KC; Stern S; Marchetto MC; Gage FH
Cell Tissue Res; 2018 Jan; 371(1):161-170. PubMed ID: 28812143
[TBL] [Abstract][Full Text] [Related]
28. [Strategy of target validation from a novel risk factor of schizophrenia / bipolar disorder].
Miyake S; Tajinda K; Matsumoto MM
Nihon Yakurigaku Zasshi; 2013 Dec; 142(6):271-5. PubMed ID: 24334924
[No Abstract] [Full Text] [Related]
29. Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review.
Saito-Diaz K; Zeltner N
Clin Auton Res; 2019 Aug; 29(4):367-384. PubMed ID: 30631982
[TBL] [Abstract][Full Text] [Related]
30. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
Suh W
Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
[TBL] [Abstract][Full Text] [Related]
31. Modeling neurodevelopmental and psychiatric diseases with human iPSCs.
Wen Z
J Neurosci Res; 2017 May; 95(5):1097-1109. PubMed ID: 28186671
[TBL] [Abstract][Full Text] [Related]
32. Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook.
Scarnati MS; Halikere A; Pang ZP
Alcohol; 2019 Feb; 74():83-93. PubMed ID: 30087005
[TBL] [Abstract][Full Text] [Related]
33. Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia.
Balan S; Toyoshima M; Yoshikawa T
Neurobiol Dis; 2019 Nov; 131():104162. PubMed ID: 29729395
[TBL] [Abstract][Full Text] [Related]
34. Schizophrenia and bipolar affective disorder: perspectives for the development of therapeutics.
Sundram S; Joyce PR; Kennedy MA
Curr Mol Med; 2003 Aug; 3(5):393-407. PubMed ID: 12942993
[TBL] [Abstract][Full Text] [Related]
35. Path from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing.
Duan J
Neurosci Bull; 2015 Feb; 31(1):113-27. PubMed ID: 25575480
[TBL] [Abstract][Full Text] [Related]
36. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
Ito D; Okano H; Suzuki N
Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches.
Corrêa-Velloso JC; Gonçalves MC; Naaldijk Y; Oliveira-Giacomelli Á; Pillat MM; Ulrich H
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt A):34-53. PubMed ID: 28476640
[TBL] [Abstract][Full Text] [Related]
38. iPSC technology: platform for drug discovery. Point.
Ellis J; Bhatia M
Clin Pharmacol Ther; 2011 May; 89(5):639-41. PubMed ID: 21512521
[TBL] [Abstract][Full Text] [Related]
39. Concise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders.
Panchision DM
Stem Cells; 2016 Mar; 34(3):523-36. PubMed ID: 26840228
[TBL] [Abstract][Full Text] [Related]
40. Neural stem cell proliferation is decreased in schizophrenia, but not in depression.
Reif A; Fritzen S; Finger M; Strobel A; Lauer M; Schmitt A; Lesch KP
Mol Psychiatry; 2006 May; 11(5):514-22. PubMed ID: 16415915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
